Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

NCT05184335 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

690

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Brilaroxazine
OTHER: Placebo

Sponsor

Reviva Pharmaceuticals